Citation Impact
Citing Papers
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
2019 StandoutScienceNobel
Structures of human PRC2 with its cofactors AEBP2 and JARID2
2018 Science
Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression
2021 StandoutNobel
Antimicrobial activity of some ethnomedicinal plants used by Paliyar tribe from Tamil Nadu, India
2006 Standout
dCas9 fusion to computer-designed PRC2 inhibitor reveals functional TATA box in distal promoter region
2022 StandoutNobel
Congenital β-lipoprotein deficiency
1966
The molecular hallmarks of epigenetic control
2016 Standout
Determining cell type abundance and expression from bulk tissues with digital cytometry
2019 Standout
Elevated Pre–Antiretroviral Therapy CD39+CD8+ T Cell Frequency Is Associated With Early Mortality in Advanced Human Immunodeficiency Virus/Tuberculosis Co-infection
2017 StandoutNobel
The emerging role of lncRNAs in cancer
2015 Standout
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations
2013
Long Noncoding RNAs in Cancer Pathways
2016 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
Natural killer cells and other innate lymphoid cells in cancer
2018
PRC2 mediated H3K27 methylations in cellular identity and cancer
2015
CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
2015
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects
2015
Long non-coding RNAs: new players in cell differentiation and development
2013 Standout
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
2006 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Retinitis pigmentosa
2006 Standout
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms
2015
Pacritinib: a new agent for the management of myelofibrosis?
2015
How to improve the immunogenicity of chemotherapy and radiotherapy
2011
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T‐cell activation
2009
Driver mutations of cancer epigenomes
2014
Idarucizumab for Dabigatran Reversal
2015 Standout
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production
1997
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
CD160 and PD-1 Co-Expression on HIV-Specific CD8 T Cells Defines a Subset with Advanced Dysfunction
2012
Coexpression of PD-1, 2B4, CD160 and KLRG1 on Exhausted HCV-Specific CD8+ T Cells Is Linked to Antigen Recognition and T Cell Differentiation
2010
Tumor Immunology and Tumor Evolution: Intertwined Histories
2020
Xist RNA Is a Potent Suppressor of Hematologic Cancer in Mice
2013
Diffuse large B-cell lymphoma
2013
Elevated Expression of CD160 and 2B4 Defines a Cytolytic HIV-Specific CD8+T-Cell Population in Elite Controllers
2015
The importance of the ratio of omega-6/omega-3 essential fatty acids
2002 Standout
Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma
2017 Standout
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cells
2013
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors
2007
The Importance of the Omega-6/Omega-3 Fatty Acid Ratio in Cardiovascular Disease and Other Chronic Diseases
2008 Standout
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Immune Modulation in Cancer with Antibodies
2013 StandoutNobel
Prevention and Treatment of Cancer-Related Infections
2012
The value of plants used in traditional medicine for drug discovery.
2001 Standout
An Ethnobotanical Survey of Herbal Drugs of Gourma District, Mali
1999
BTLA expression contributes to septic morbidity and mortality by inducing innate inflammatory cell dysfunction
2012
Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients
2011
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Allicin: Chemistry and Biological Properties
2014 Standout
Liposomal Formulations in Clinical Use: An Updated Review
2017 Standout
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
2014
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967 Standout
Electroretinographic Responses Following Vitamin A Therapy in A-Beta-Lipoproteinemia
1972
Immune‐Related Adverse Events From Immune Checkpoint Inhibitors
2016
A systematic dissection of determinants and consequences of snoRNA-guided pseudouridylation of human mRNA
2022 StandoutNobel
Prosthetic Joint Infection
2014 Standout
The Frequency of CD127 + Hepatitis C Virus (HCV)-Specific T Cells but Not the Expression of Exhaustion Markers Predicts the Outcome of Acute HCV Infection
2013 StandoutNobel
Apoptotic killing of B-chronic lymphocytic leukemia tumor cells by allicin generated in situ using a rituximab-alliinase conjugate
2005
Small RNAs with big implications: new insights into H/ACA snoRNA function and their role in human disease
2014
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
POEMS syndrome: definitions and long-term outcome
2003
Works of Jérôme Rey being referenced
Rare mutations in DNMT3A in myeloproliferative neoplasms and myelodysplastic syndromes
2011
JC papovavirus leukoencephalopathy after first line treatment with CHOP and rituximab
2007
New approaches in the immunotherapy of haematological malignancies
2003
Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms
2012
Antithymocyte Globulin in Reduced-Intensity Conditioning Regimen Allows a High Disease-Free Survival Exempt of Long-Term Chronic Graft-versus-Host Disease
2013
Effects of SK&F 104353, a leukotriene receptor antagonist, on the bronchial responses to histamine in subjects with asthma: A comparative study with terfenadine
1990
The co‐expression of 2B4 (CD244) and CD160 delineates a subpopulation of human CD8+ T cells with a potent CD160‐mediated cytolytic effector function
2006
Determinants of surgical site infection after breast biopsy
2005
Natural Killer Cell-triggering Receptors in Patients with Acute Leukaemia
2003
A role for HVEM, but not lymphotoxin‐β receptor, in LIGHT‐induced tumor cell death and chemokine production
2009
Natural killer and γδ T cells in haematological malignancies: enhancing the immune effectors
2009
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma
2006
Renal involvement in POEMS syndrome.
1995
NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
2017
Mutations and deletions of the SUZ12 polycomb gene in myeloproliferative neoplasms
2011
NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML
2017
A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies
2018
A phase 1 dose-escalation study of IPH2102 (lirilumab, BMS-986015, LIRI), a fully human anti KIR monoclonal antibody (mAb) in patients (pts) with various hematologic (HEM) or solid malignancies (SOL).
2015
Efficacy and safety of pegylated‐interferon α‐2a in myelofibrosis: a study by the FIM and GEM French cooperative groups
2013
Hepatitis B surface antigen (HBsAg) inactivation and angiotensin‐converting enzyme (ACE) inhibition in vitro by Combretum glutinosum perr. (Combretaceae) extract
1993
Array comparative genomic hybridization and sequencing of 23 genes in 80 patients with myelofibrosis at chronic or acute phase
2013
Congenital Absence of Beta-Lipoproteins
1963